The association of IL28B genotype with peginterferon-α/ribavirin ( PR) treatment outcome and liver interferon-stimulated gene (ISG) expression is determined by HCV genotype

被引：0
|
作者：
Holmes, Jacinta A. [1 ,2 ]
Congiu, Mario [2 ]
Bonanazinga, Sara [3 ]
Sandhu, Manjeet K. [1 ]
Kia, Yin H. [1 ]
Bell, Sally [1 ]
Visvanathan, Kumar [4 ]
Sievert, William [4 ]
Bowden, Scott [3 ]
Desmond, Paul V. [1 ,2 ]
Thompson, Alexander J. [1 ,2 ]
机构：
[1] St Vincents Hosp, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Carlton, Vic 3053, Australia
[3] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[4] Monash Univ, Monash Med Ctr, Clayton, Vic, Australia
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1822
引用
收藏
页码：1042A / 1043A
页数：2
相关论文
共 50 条
  • [31] Interferon-Stimulated Gene Expression Is Associated With Treatment Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Patients With Chronic HCV Genotype-1 Infection
    Datsenko, Yakov
    Baum, Patrick
    Schirmbeck, Reinhold
    Stern, Jerry O.
    Sha, Nanshi
    Steinmann, Gerhard G.
    GASTROENTEROLOGY, 2014, 146 (05) : S965 - S966
  • [32] IL28B Genotype Effects During Early Treatment with Peginterferon and Ribavirin in Difficult-to-Treat Hepatitis C Virus Infection
    Scott, John
    Holte, Sarah
    Urban, Thomas
    Burgess, Caitlin
    Coppel, Erica
    Wang, Chia
    Corey, Larry
    McHutchison, John
    Goldstein, David
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (03): : 419 - 425
  • [33] Treatment Response, IFNL3 (IL28B) and IFNL4 Genotype and Hepatic Expression of Interferons and Interferon-Stimulated Genes in Patients with Chronic Hepatitis C
    Noureddin, Mazen
    Rotman, Yaron
    Thomas, Emmanuel
    Zhang, Fang
    Park, Heiyoung
    Rehermann, Barbara
    Liang, T. Jake
    HEPATOLOGY, 2014, 60 : 1057A - 1057A
  • [34] IFN Stimulated Gene Expression in the Liver is a Better Predictor of Treatment Response in Chronic Hepatitis C than the IL28B (IFNλ3) Genotype
    Dill, Michael T.
    Duong, Francois H. T.
    Vogt, Julia E.
    Bibert, Stephanie
    Bochud, Pierre-Yves
    Terracciano, Luigi
    Papassotiropoulos, Andreas
    Roth, Volker
    Heim, Markus H.
    SWISS MEDICAL WEEKLY, 2010, 140 : 4S - 4S
  • [35] IFN STIMULATED GENE EXPRESSION IN THE LIVER IS A BETTER PREDICTOR OF TREATMENT RESPONSE IN CHRONIC HEPATITIS C THAN THE IL28B (IFNλ3) GENOTYPE
    Dill, M. T.
    Duong, F. H. T.
    Vogt, J. E.
    Bibert, S.
    Bochud, P. -Y.
    Terracciano, L.
    Papassotiropoulos, A.
    Roth, V.
    Heim, M. H.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S461 - S461
  • [36] IFN stimulated gene expression in the liver is a better predictor of treatment response in chronic hepatitis C than the IL28B (IFNλ3) genotype
    Dill, Michael T.
    Duong, Francois H. T.
    Vogt, Julia E.
    Bibert, Stephanie
    Bochud, Pierre-Yves
    Terracciano, Luigi
    Papassotiropoulos, Andreas
    Roth, Volker
    Heim, Markus H.
    CYTOKINE, 2010, 52 (1-2) : 41 - 41
  • [37] Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease
    El-Awady, Mostafa K.
    Mostafa, Lotiaf
    Tabll, Ashraf A.
    Abdelhafez, Tawfeek H.
    El Din, Noha G. Bader
    Zayed, Naglaa
    El Shenawy, Reem
    El Abd, Yasmin
    Hasan, Reham M.
    Zaghlol, Hosam
    El Khayat, Hesham
    Aziz, Ashraf O. Abdel
    HEPATITIS MONTHLY, 2012, 12 (04) : 271 - 277
  • [38] High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV
    Katsounas, Antonios
    Hubbard, Jonathan J.
    Wang, Crystal H.
    Zhang, Xiaozhen
    Dou, Diana
    Shivakumar, Bhavana
    Winter, Sophie
    Schlaak, Joerg F.
    Lempicki, Richard A.
    Masur, Henry
    Polis, Michael
    Kottilil, Shyam
    Osinusi, Anu
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (06) : 959 - 963
  • [39] PRE-TREATMENT IP-10 LEVELS AND IL28B GENOTYPE IN PREDICTION OF SVR IN PRIOR TREATMENT-EXPERIENCED GENOTYPE 1 HCV PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/ RIBAVIRIN IN THE REALIZE STUDY
    Vijgen, L.
    Talloen, W.
    Scholliers, A.
    Johansson, S.
    Tuefferd, M.
    De Meyer, S.
    Witek, J.
    Fanning, G.
    Picchio, G.
    Pol, S.
    Zeuzem, S.
    Aerssens, J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S462 - S462
  • [40] IMPACT OF IL28B POLYMORPHISM ON TREATMENT DURATION IN HCV GENOTYPE 1 AND 4 PATIENTS
    Scherzer, Thomas-Matthias
    Staettermayer, Albert
    Kessler, Harald H.
    Gschwantler, Michael
    Strasser, Michael P.
    Laferl, Hermann
    Maieron, Andreas
    Stauber, Rudolf E.
    Datz, Christian
    Rutter, Karoline
    Beinhardt, Sandra
    Steindl-Munda, Petra E.
    Hofer, Harald
    Ferenci, Peter
    HEPATOLOGY, 2010, 52 (04) : 765A - 765A
12345